Founded in 2014, Wuhan bms Medicaltech Co.,Ltd. specializes in core technologies and products applied to blood transfusion, cell and gene therapy, and biopharmaceuticals. It is a high-tech enterprise integrating R&D, production, and global sales.bms developed China’s first innovative sterile tube welding product, breaking the 25-year monopoly of Japanese and German products in the Chinese market.Leveraging this core technology, the product has been marketed since 2019 and is now sold in 46 countries and regions.The second core technology, blood separation products, entered the market in 2024 and has been sold in 8 countries.
bms Core Technologies
The two core products have achieved mass production, with domestic and international sales accounting for approximately 25% and 75%, respectively.
bms has developed a diverse product portfolio covering sterile tube welder, autologous serum preparation, whole blood separation, tube sealing, and intelligent blood collection. Applications span blood transfusion (BCT), cell and gene therapy (CGT), biopharmaceuticals (BP), and ophthalmic ASE treatments, with broad usage scenarios and significant market potential.
bms Patent Qualification
Adhering to the values of innovation and quality, bms has obtained 62 patents, including 14 for inventions, with a total of 167 patent applications. Core technologies are also patented in the U.S., Germany, and France.
Several products have received Chinese medical product registration certificates, EU CE certification, and U.S. FDA approval.
|
|
